BioStock: Evaxion establishes two Big Pharma partnerships

Evaxion Biotech has recently announced several key developments, including a partnership with Afrigen Biologics aimed at developing a prophylactic vaccine against gonorrhoea. They also initiated a new vaccine programme through another high profile, still undisclosed, collaboration. BioStock reached out to the company’s CEO Christian Kanstrup to learn more.

Read the interview with Christian Kanstrup at biostock.se:

Evaxion establishes two Big Pharma partnerships - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/